We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
IL-12 is a heterodimeric cytokine, encoded by IL-12A and IL-12B genes, responsible for the p35 and p40 subunits respectively. It is produced by macrophages and B lymphocytes and has a broad range of effects, including the activation of T cells and Natural Killer (NK) cells (1,2). A key effect includes inducing production of IFN-γ and TNF-α by resting and activating T and NK cells through STAT4 pathway which represents a critical path for T cell-dependent induction of IFN-γ (3). This function is necessary for fighting bacterial and parasitic infections, activation of differentiated T lymphocytes, and development of Th1 response. hIL-12 is therefore understood to be a critical link between innate and adaptive immune responses (3,4).
Product images on the website are not representative of actual product, including, but not limited to differences in cap color, tube type, or label format.


Figure 1. Western Blot image showing detection of rh IL-12 bands


Figure 2. Recombinant Human IL-12 activity induces bioluminiscence upon binding to receptor on IL-12 BioAssay Cells


Figure 3. Recombinant Human IL-12 activity induces bioluminiscence upon binding to receptor on IL-12 BioAssay Cells
Centrifuge vial before opening. Suspend the product by gently pipetting the above recommended solution down the sides of the vial. DO NOT VORTEX. Allow several minutes for complete reconstitution. For prolonged storage, dilute to working aliquots in a 0.1% BSA solution, store at -80°C and avoid repeat freeze thaws.
| Alternate Names | p70, Natural Killer Cell Stimulatory Factor (NKSF) or Cytotoxic Lymphocyte Maturation Factor (CLMF) |
| Accession Number | P29460/P29459 |
| Source | CHO cells |
| Predicted Molecular Mass | GS-linked Heterodimer, 58.7 kDa (523 aa) |
| AA Sequence | IWELKKDVYV VELDWYPDAP GEMVVLTCDT PEEDGITWTL DQSSEVLGSG KTLTIQVKEF GDAGQYTCHK GGEVLSHSLL LLHKKEDGIW STDILKDQKE PKNKTFLRCE AKNYSGRFTC WWLTTISTDL TFSVKSSRGS SDPQGVTCGA ATLSAERVRG DNKEYEYSVE CQEDSACPAA EESLPIEVMV DAVHKLKYEN YTSSFFIRDI IKPDPPKNLQ LKPLKNSRQV EVSWEYPDTW STPHSYFSLT FCVQVQGKSK REKKDRVFTD KTSATVICRK NASISVRAQD RYYSSSWSEW ASVPCSGSGS SRGGSGSGGS GGGGSKRNLP VATPDPGMFP CLHHSQNLLR AVSNMLQKAR QTLEFYPCTS EEIDHEDITK DKTSTVEACL PLELTKNESC LNSRETSFIT NGSCLASRKTSFMMALCLSS IYEDLKMYQV EFKTMNAKLL MDPKRQIFLD QNMLAVIDEL MQALNFNSET VPQKSSLEEP DFYKTKIKLC ILLHAFRIRA VTIDRVMSYL NAS |
| Formulation | Lyophilized from a 0.2 µm filtered solution containing 10 mM NaP, 30 mM NaCl, pH 7.2 |
| Product Reconstitution | Sterile water at 0.1 mg/mL |
| Country of Origin | USA |
| Specification* | Method of Determination | Acceptance Criteria |
| Purity | Reducing and Non-Reducing SDS PAGE | ≥ 98% |
| Endotoxin | Kinetic LAL (50% confidence) | ≤ 0.1 EU/µg |
| Biological Activity (ED50) | Ability to induce Bioluminescence in engineered IL-12 bioassay cells | ≤ 2.5 ng/mL; 4.0 x 105 units/mg |
*Lot-specific values for the above specifications are supplied with each product on its corresponding COA. The values provided here are minimum expected values to pass internal requirements.
References: